Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concentration of intravitreally injected triamcinolone acetonide in aqueous humour.

Literature DB >> 12185144

Concentration of intravitreally injected triamcinolone acetonide in aqueous humour.

Jost B Jonas¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2002 PMID： 12185144 PMCID： PMC1771272 DOI： 10.1136/bjo.86.9.1066

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

6 in total

1. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.

Authors: R P Danis; T A Ciulla; L M Pratt; W Anliker
Journal: Retina Date: 2000 Impact factor: 4.256

2. Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye.

Authors: R Machemer
Journal: Retina Date: 1996 Impact factor: 4.256

3. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy.

Authors: J B Jonas; J K Hayler; A Söfker; S Panda-Jonas
Journal: Am J Ophthalmol Date: 2001-04 Impact factor: 5.258

4. Treatment of intraocular proliferations with intravitreal steroids.

Authors: R Machemer; G Sugita; Y Tano
Journal: Trans Am Ophthalmol Soc Date: 1979

5. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors: J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal: Aust N Z J Ophthalmol Date: 1998-11

6. The clearance of intravitreal triamcinolone acetonide.

Authors: R H Schindler; D Chandler; R Thresher; R Machemer
Journal: Am J Ophthalmol Date: 1982-04 Impact factor: 5.258

6 in total

12 in total

1. Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Authors: J B Jonas; I Kreissig; R F Degenring
Journal: Br J Ophthalmol Date: 2004-12 Impact factor: 4.638

2. Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Authors: J B Jonas; I Kreissig; P Hugger; G Sauder; S Panda-Jonas; R Degenring
Journal: Br J Ophthalmol Date: 2003-04 Impact factor: 4.638

3. Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors: B R Kosobucki; W R Freeman; L Cheng
Journal: Br J Ophthalmol Date: 2006-03-10 Impact factor: 4.638

4. Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.

Authors: Marianne L Shahsuvaryan
Journal: Int J Ophthalmol Date: 2012-12-18 Impact factor: 1.779

5. Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.

Authors: T Kube; M Sutter; R Trittler; N Feltgen; L L Hansen; H T Agostini
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-05-20 Impact factor: 3.117